1. Home
  2. KTTA vs UPC Comparison

KTTA vs UPC Comparison

Compare KTTA & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • UPC
  • Stock Information
  • Founded
  • KTTA 2020
  • UPC 1998
  • Country
  • KTTA United States
  • UPC China
  • Employees
  • KTTA N/A
  • UPC N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KTTA Health Care
  • UPC Health Care
  • Exchange
  • KTTA Nasdaq
  • UPC Nasdaq
  • Market Cap
  • KTTA 2.8M
  • UPC 2.2M
  • IPO Year
  • KTTA 2021
  • UPC 2021
  • Fundamental
  • Price
  • KTTA $0.72
  • UPC $3.76
  • Analyst Decision
  • KTTA
  • UPC
  • Analyst Count
  • KTTA 0
  • UPC 0
  • Target Price
  • KTTA N/A
  • UPC N/A
  • AVG Volume (30 Days)
  • KTTA 192.8K
  • UPC 70.0K
  • Earning Date
  • KTTA 08-12-2025
  • UPC 07-11-2025
  • Dividend Yield
  • KTTA N/A
  • UPC N/A
  • EPS Growth
  • KTTA N/A
  • UPC N/A
  • EPS
  • KTTA N/A
  • UPC N/A
  • Revenue
  • KTTA N/A
  • UPC $23,024,458.00
  • Revenue This Year
  • KTTA N/A
  • UPC N/A
  • Revenue Next Year
  • KTTA N/A
  • UPC N/A
  • P/E Ratio
  • KTTA N/A
  • UPC N/A
  • Revenue Growth
  • KTTA N/A
  • UPC N/A
  • 52 Week Low
  • KTTA $0.70
  • UPC $2.51
  • 52 Week High
  • KTTA $7.50
  • UPC $2,592.00
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 33.76
  • UPC 41.11
  • Support Level
  • KTTA $0.71
  • UPC $3.45
  • Resistance Level
  • KTTA $0.76
  • UPC $4.10
  • Average True Range (ATR)
  • KTTA 0.04
  • UPC 0.23
  • MACD
  • KTTA 0.01
  • UPC -0.03
  • Stochastic Oscillator
  • KTTA 8.59
  • UPC 37.78

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: